Company Overview
Company Name
Alnylam Pharmaceuticals
Address
675 W Kendall St, Cambridge, MA, 02142, United States
Website
alnylam.comPhone
(617) 551-8200Approx. Annual Revenue
$180.0M
Employees
1,000
Established
2002
Locations
2
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, with approximately 1,001 employees. The company focuses on developing RNAi therapeutics for the treatment of amyloidosis, hyperoxaluria, and porphyria, leveraging its proprietary delivery platforms and pipeline of clinical-stage programs.
Business Profile
Read from the Alnylam Pharmaceuticals website on Oct 12, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 9/10 · Current news and annual report; Comprehensive navigation and resources
- Footer copyright year
- 2026
Alnylam Pharmaceuticals locations
2 Google Business Profile listings.
| Location | Google category | Reviews | Status |
|---|---|---|---|
| 675 W Kendall St, Cambridge, MAprimary | — | — | Claimed |
| 20 Commerce Way, Norton, MA | Pharmaceutical company | — | Claimed |
Biotech & Life Sciences Companies near Cambridge, MA
Browse all Biotech & Life Sciences companies in Massachusetts →
Frequently Asked Questions about Alnylam Pharmaceuticals
Categories
Technologies Used
'%20fill='%23CE1312'%3e%3cpath%20d='M219.044,391.269916%20L219.0425,377.687742%20L232.0115,384.502244%20L219.044,391.269916%20Z%20M247.52,375.334163%20C247.52,375.334163%20247.0505,372.003199%20245.612,370.536366%20C243.7865,368.610299%20241.7405,368.601235%20240.803,368.489448%20C234.086,368%20224.0105,368%20224.0105,368%20L223.9895,368%20C223.9895,368%20213.914,368%20207.197,368.489448%20C206.258,368.601235%20204.2135,368.610299%20202.3865,370.536366%20C200.948,372.003199%20200.48,375.334163%20200.48,375.334163%20C200.48,375.334163%20200,379.246723%20200,383.157773%20L200,386.82561%20C200,390.73817%20200.48,394.64922%20200.48,394.64922%20C200.48,394.64922%20200.948,397.980184%20202.3865,399.447016%20C204.2135,401.373084%20206.612,401.312658%20207.68,401.513574%20C211.52,401.885191%20224,402%20224,402%20C224,402%20234.086,401.984894%20240.803,401.495446%20C241.7405,401.382148%20243.7865,401.373084%20245.612,399.447016%20C247.0505,397.980184%20247.52,394.64922%20247.52,394.64922%20C247.52,394.64922%20248,390.73817%20248,386.82561%20L248,383.157773%20C248,379.246723%20247.52,375.334163%20247.52,375.334163%20L247.52,375.334163%20Z'%20id='Youtube'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Social Profiles
Key Decision Makers
Kwame Boateng Director
Laura Doyle Senior Director, Clinical Operations
Kenasha J. Manager, Clinical Operations
Melanie Keltz Clinical Trial Specialist
Rose Kaplan Clinical Trial Manager
Jeremy Whitley Clinical Trial Manager
Sofia Moniz Clinical Trial Manager
Jacob Martin Clinical Trial Manager
Vanessa Bahnam Clinical Trial Manager
Terry Maratos-Flier Director Clinical Research